focused on the diagnostic value of various autoantibodies across different organs, as well as the application of ACE inhibitors in patients with renal involvement, exploring the role of ARAs and anti-fibrinogen antibodies (AFAs) in diagnosing SSc-related renal involvement [32,33]. This evidence concerns the gene ACE and systemic sclerosis.